Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AbbVie Announces Humira Global Patent License with Pfizer

americanpharmaceuticalreviewDecember 03, 2018

Tag: AbbVie , Pfizer , Patent License , biosimilar adalimumab product

PharmaSources Customer Service